Workflow
江苏吉贝尔药业股份有限公司2025年半年度权益分派实施公告

Core Viewpoint - Jiangsu Jibeier Pharmaceutical Co., Ltd. has announced a cash dividend distribution of 0.26 yuan per share (including tax) for the first half of 2025, totaling approximately 51.85 million yuan [2][5]. Summary by Sections Dividend Distribution Plan - The profit distribution plan was authorized by the shareholders' meeting on May 28, 2025, and approved by the board of directors on August 29, 2025 [2][3]. - The distribution amount does not exceed the net profit attributable to shareholders for the first half of 2025 [3]. Distribution Details - The total number of shares before the distribution is 199,430,865 [5]. - The cash dividend will be distributed to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the day before the dividend record date [4]. Implementation Method - The dividends will be distributed through the clearing system of the China Securities Depository and Clearing Corporation for shareholders who have completed designated transactions [7]. - Specific entities, such as Zhenjiang Zhongtian Investment Consulting Co., Ltd. and Nantong Huirui Investment Co., Ltd., will receive dividends directly from the company [8]. Taxation Information - For individual shareholders holding shares for over one year, the dividend income is exempt from personal income tax, resulting in an actual cash dividend of 0.26 yuan per share [9]. - For shares held for less than one year, the company will not withhold personal income tax at the time of distribution, but tax will be calculated and deducted upon the transfer of shares [10]. - For Qualified Foreign Institutional Investors (QFIIs), a 10% withholding tax will apply, resulting in a net cash dividend of 0.234 yuan per share [11].